相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ledipasvir/Sofosbuvir Regimens for Chronic Hepatitis C Infection: Insights From a Work Productivity Economic Model From the United States
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1,-2, and-3 clinical trials
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
Jane P. Messina et al.
HEPATOLOGY (2015)
Work productivity among treatment-naive patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment
J. Aggarwal et al.
JOURNAL OF VIRAL HEPATITIS (2015)
The societal burden of chronic liver diseases: results from the COME study
Luciana Scalone et al.
BMJ OPEN GASTROENTEROLOGY (2015)
The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions
Mina Kabiri et al.
ANNALS OF INTERNAL MEDICINE (2014)
Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Sofosbuvir-Containing Regimens
Zobair M. Younossi et al.
HEPATOLOGY (2014)
Hepatitis C and Work Impairment A Review of Current Literature
Vignan Manne et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Global epidemiology and genotype distribution of the hepatitis C virus infection
Erin Gower et al.
JOURNAL OF HEPATOLOGY (2014)
Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H. Razavi et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P. Bruggmann et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries
Jeffrey Vietri et al.
BMC GASTROENTEROLOGY (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Socioeconomic status in HCV infected patients – risk and prognosis
Lars Haukali Omland et al.
Clinical Epidemiology (2013)
The Burden of Untreated Hepatitis C Virus Infection: A US Patients' Perspective
Antoine C. El Khoury et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes
Marco daCosta DiBonaventura et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Markus Cornberg et al.
LIVER INTERNATIONAL (2011)
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities
Marco daCosta DiBonaventura et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver
Ira M. Jacobson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
IHCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
Nikolai Muehlberger et al.
BMC PUBLIC HEALTH (2009)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C
R Perrillo et al.
JOURNAL OF VIRAL HEPATITIS (2004)
分享论文
